Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+46.3%
5Y CAGR+32.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+46.3%/yr
vs +21.5%/yr prior
5Y CAGR
+32.1%/yr
Recent acceleration
Acceleration
+24.8pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $243.96M | +7.1% |
| 2024 | $227.76M | -12.2% |
| 2023 | $259.43M | +232.7% |
| 2022 | $77.97M | +17.1% |
| 2021 | $66.56M | +9.6% |
| 2020 | $60.73M | +9.0% |
| 2019 | $55.72M | +55.7% |
| 2018 | $35.80M | +91.6% |
| 2017 | $18.68M | -3.1% |
| 2016 | $19.28M | - |